Glassman Wealth Services’s Blonder Tongue Laboratories Inc BDR Stock Holding History

Glassman Wealth Services’s Portfolio BDR Stock Details BDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-75	Closed	–	–	2029
2021 Q3	$0	Buy	+75	New	+$92	﹤0.01%	1897

Other funds holding BDR

TCM

Tufton Capital Management Hunt Valley, Maryland $596M AUM 37.37% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Glassman Wealth Services's BDR Position: Q4 2021 in Review

Glassman Wealth Services sold out of Blonder Tongue Laboratories Inc (BDR) in Q4 2021, closing a stake of 75 shares.

Glassman Wealth Services first reported a position in BDR in Q3 2021 and held it in 1 quarter. The position peaked at $0 in Q3 2021. 9 funds tracked by Wall St. Rank hold BDR as of Q4 2021.

Glassman Wealth Services reported no remaining Blonder Tongue Laboratories Inc position as of Q4 2021 after selling out during the quarter.
Glassman Wealth Services sold 75 Blonder Tongue Laboratories Inc shares in Q4 2021.
Glassman Wealth Services first reported a position in Blonder Tongue Laboratories Inc in Q3 2021 and held it in 1 quarter.
Glassman Wealth Services's Blonder Tongue Laboratories Inc position peaked at $0 in Q3 2021.
9 funds tracked by Wall St. Rank held Blonder Tongue Laboratories Inc as of Q4 2021.

Based on Glassman Wealth Services's 13F filing for Q4 2021, filed 14 Feb 2022.